The Anomali Platform Advances Intelligence-Driven Detection and Response Capabilities and Prevents Business Disruptions While Optimizing Security Expense
15.9.2022 02:46:00 EEST | Business Wire | Press release
Anomali, the leader in intelligence-driven cybersecurity solutions, announced the general availability today of its quarterly platform update to meet the expanding needs of its customers and partners. This release introduces new capabilities to enhance Anomali’s threat intelligence and extended detection and response (XDR) use cases that enable enterprise organizations to stay one step ahead of adversaries and prevent business disruptions while optimizing security expenses.
“Anomali’s August release offers new capabilities and enhancements for security operations teams struggling to identify not only who’s targeting them, but how and why they are being targeted,” said Mark Alba, Chief Product Officer at Anomali.
Key highlights of this release include:
Creating Extended Visibility with Anomali Attack Pattern Detection and MITRE ATT&CK®: In 2021, Anomali joined MITRE Engenuity’s Center for Threat-Informed Defense to collaborate on the Attack Flow Project to better understand adversary behavior and improve defensive capabilities. This partnership culminated with the public release of the project in March 2022.
Since then, Anomali has been working to incorporate attack flows into The Anomali Platform. This release moves the platform toward an Attack Flow Library for Anomali ThreatStream that will provide an access point for new Attack Flows that sequence cyberattack techniques. This capability will provide a new context around adversary behavior and help security teams expertly profile the adversary. It will also enable them better to protect the organization in advance of an attack, detect an attack in real-time, and respond post-attack.
Furthermore, this predictive visual mapping will be leveraged by CISOs and security professionals to align attacks with potential holes in their security posture to get in front of the threat.
“ESG research found that 97% of security professionals believe that MITRE ATT&CK is important to their organization’s security operations strategy,” said Jon Oltsik, Senior Principal Analyst and Fellow, ESG Research. “Anomali’s commitment to integrating the MITRE ATT&CK Framework into its solutions and participating in the MITRE Engenuity Center for Threat Informed Defense can help security teams adopt the framework and better understand cyber-adversaries.”
Routine Workflow Automation: Given macro-economic conditions, customers are looking for capabilities that make their existing investments more impactful. We’ve introduced a new extensible framework to support the automation of routine tasks throughout the platform. This release's first implementation is available to automate enrichments in the investigations workbench. A drag-and-drop process for configuring a multi-stage enrichment task can easily be set and run when conditions require it, saving analysts time performing repetitive tasks.
Additional enhancements with this platform release include:
- Support for MITRE ATT&CK Mobile & ICS: Intelligence aggregation, contextualization, and analysis for Mobile and ICS attack surfaces to strengthen overall security posture.
- MITRE ATT&CK Enterprise v11 in Anomali Lens
- Scheduled Retrospective Search: Helps the SOC automate the correlation of historical events with newly available intelligence to produce reports and gain insight into threat actors, TTPs, or other adversary behavior. This new capability enables CISOs to detect real-time threats in their local IT environment.
Anomali will be exhibiting at BlackHat on August 10 & 11, Booth #3034. Stop by to chat with the team and learn more about our intelligence-driven solutions.
About Anomali
Anomali is the leader in intelligence-driven extended detection and response (XDR) cybersecurity solutions. Anchored by big data management (the “X”) and refined by artificial intelligence, The Anomali Platform, an XDR solution, delivers unique proprietary capabilities that correlate the largest repository of global intelligence with telemetry from customer-deployed security solutions. This combination empowers security operations teams to accurately detect threats, optimize response, achieve resiliency, and ultimately stop attackers and breaches. Our SaaS-based solutions easily integrate into existing security tech stacks through native-cloud, multi-cloud, on-premises, and hybrid deployments. Founded in 2013, Anomali serves global B2B enterprise businesses, large public sector organizations, ISACs, ISAOs, service providers, and Global 1000 customers to help safeguard the world’s critical infrastructure, companies, and people. Leading venture firms, including Google Ventures, General Catalyst, and IVP, back Anomali. Learn more at www.anomali.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220808005789/en/
Contact information
Karen Buffo
news@anomali.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 23:01:00 EEST | Press release
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 16:00:00 EEST | Press release
NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under 20 minutes, saving hundreds of hours of engineer time, shrinking MTTR by more than 95%. A global telecommunications firm found NetBrain's context-grounded agents outperformed a stand-alone frontier LLM on a persistent firewall
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 15:00:00 EEST | Press release
Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consistent approach to protecting our innovation and our customers,” said Justin Ferguson, SVP and general counsel at Adtran. “We take all claims seriously, but we will not hesitate to defend ourselves when assertions lack merit. Situations like this place unnecessary strain on technology providers and divert resources from advancing networks and services. By advancing our counterclaim
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 14:00:00 EEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 13:50:00 EEST | Press release
IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio transformation and is expected to strengthen the company’s focus on its innovation-driven businesses: Taste, Scent, and Health & Biosciences. Following the transaction, IFF will be
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
